PL2202225T3 - Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym - Google Patents

Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym

Info

Publication number
PL2202225T3
PL2202225T3 PL09290990T PL09290990T PL2202225T3 PL 2202225 T3 PL2202225 T3 PL 2202225T3 PL 09290990 T PL09290990 T PL 09290990T PL 09290990 T PL09290990 T PL 09290990T PL 2202225 T3 PL2202225 T3 PL 2202225T3
Authority
PL
Poland
Prior art keywords
pharmaceutically acceptable
acceptable acid
new method
added salts
ivabradine
Prior art date
Application number
PL09290990T
Other languages
English (en)
Inventor
Jean-Louis Peglion
AIMéE DESSINGES
Bernard Serkiz
Jean-Michel Lerestif
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40823411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2202225(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL2202225T3 publication Critical patent/PL2202225T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL09290990T 2008-12-24 2009-12-23 Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym PL2202225T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0807444A FR2940287B1 (fr) 2008-12-24 2008-12-24 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
EP09290990A EP2202225B1 (fr) 2008-12-24 2009-12-23 Nouveau procédé de synthèse de l'ivabradine et de ses sels d'addition à un acide pharmaceutiquemenet acceptable

Publications (1)

Publication Number Publication Date
PL2202225T3 true PL2202225T3 (pl) 2013-01-31

Family

ID=40823411

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09290990T PL2202225T3 (pl) 2008-12-24 2009-12-23 Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym

Country Status (36)

Country Link
US (1) US8097720B2 (pl)
EP (1) EP2202225B1 (pl)
JP (1) JP5276579B2 (pl)
KR (1) KR101064413B1 (pl)
CN (1) CN101759643B (pl)
AR (1) AR074845A1 (pl)
AU (1) AU2009245875B2 (pl)
BR (1) BRPI0905147A8 (pl)
CA (1) CA2688815C (pl)
CL (1) CL2009002201A1 (pl)
DK (1) DK2202225T3 (pl)
EA (1) EA016405B1 (pl)
ES (1) ES2398332T3 (pl)
FR (1) FR2940287B1 (pl)
GE (1) GEP20125491B (pl)
HK (1) HK1145833A1 (pl)
HR (1) HRP20121044T1 (pl)
JO (1) JO2807B1 (pl)
MA (1) MA31498B1 (pl)
ME (1) ME02037B (pl)
MX (1) MX2009013480A (pl)
MY (1) MY148288A (pl)
NZ (1) NZ582310A (pl)
PA (1) PA8855501A1 (pl)
PE (1) PE20100487A1 (pl)
PL (1) PL2202225T3 (pl)
PT (1) PT2202225E (pl)
RS (1) RS52542B (pl)
SA (1) SA109310011B1 (pl)
SG (1) SG162671A1 (pl)
SI (1) SI2202225T1 (pl)
TW (1) TWI385153B (pl)
UA (1) UA102518C2 (pl)
UY (1) UY32311A (pl)
WO (1) WO2010072930A1 (pl)
ZA (1) ZA200909109B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101478855B1 (ko) 2007-05-30 2015-01-02 인드-스위프트 래버러토리즈 리미티드 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법
US11164672B2 (en) 2010-01-22 2021-11-02 Deka Products Limited Partnership System and apparatus for electronic patient care
US11210611B2 (en) 2011-12-21 2021-12-28 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US20110313789A1 (en) 2010-01-22 2011-12-22 Deka Products Limited Partnership Electronic patient monitoring system
US11881307B2 (en) 2012-05-24 2024-01-23 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US11244745B2 (en) 2010-01-22 2022-02-08 Deka Products Limited Partnership Computer-implemented method, system, and apparatus for electronic patient care
US10911515B2 (en) 2012-05-24 2021-02-02 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US10453157B2 (en) 2010-01-22 2019-10-22 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
CN102464595B (zh) * 2010-11-17 2015-02-25 山东新时代药业有限公司 一种伊伐布雷定中间体的合成方法
FR2971507B1 (fr) * 2011-02-14 2013-01-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP2495237A1 (en) 2011-03-04 2012-09-05 Alembic Pharmaceuticals Limited An improved process for the preparation of highly pure ivabradine hydrochloride
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984319B1 (fr) * 2011-12-20 2013-12-27 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
CN103848789B (zh) * 2012-11-29 2016-05-18 江苏恒瑞医药股份有限公司 一种伊伐布雷定的制备方法
CN103864690B (zh) * 2014-01-06 2016-09-14 北京莱瑞森医药科技有限公司 伊伐布雷定盐酸盐的s晶型、其制备方法和药物组合物
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN113372274B (zh) * 2020-03-10 2023-03-24 鲁南制药集团股份有限公司 一种伊伐布雷定的制备方法
CN113372273B (zh) * 2020-03-10 2023-05-09 鲁南制药集团股份有限公司 一种伊伐布雷定中间体化合物iv
JP7108650B2 (ja) 2020-03-11 2022-07-28 株式会社カナモト 車両の自動遠隔操縦装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
WO2008065681A2 (en) * 2006-11-30 2008-06-05 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
KR101478855B1 (ko) * 2007-05-30 2015-01-02 인드-스위프트 래버러토리즈 리미티드 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법

Also Published As

Publication number Publication date
US8097720B2 (en) 2012-01-17
TW201028385A (en) 2010-08-01
SI2202225T1 (sl) 2013-01-31
CA2688815A1 (fr) 2010-06-24
EA200901563A1 (ru) 2010-06-30
TWI385153B (zh) 2013-02-11
DK2202225T3 (da) 2013-02-11
EA016405B1 (ru) 2012-04-30
ZA200909109B (en) 2010-09-29
UY32311A (es) 2010-06-30
CN101759643A (zh) 2010-06-30
MY148288A (en) 2013-03-29
BRPI0905147A8 (pt) 2021-04-06
MA31498B1 (fr) 2010-07-01
FR2940287B1 (fr) 2010-12-24
NZ582310A (en) 2010-11-26
PT2202225E (pt) 2012-11-15
KR20100075413A (ko) 2010-07-02
ES2398332T3 (es) 2013-03-15
BRPI0905147A2 (pt) 2011-03-22
MX2009013480A (es) 2010-06-23
JO2807B1 (en) 2014-09-15
KR101064413B1 (ko) 2011-09-14
WO2010072930A1 (fr) 2010-07-01
RS52542B (en) 2013-04-30
PE20100487A1 (es) 2010-07-22
AU2009245875B2 (en) 2011-02-24
CN101759643B (zh) 2012-05-16
GEP20125491B (en) 2012-04-25
CA2688815C (fr) 2012-01-31
EP2202225A1 (fr) 2010-06-30
CL2009002201A1 (es) 2010-10-29
FR2940287A1 (fr) 2010-06-25
US20100160628A1 (en) 2010-06-24
HK1145833A1 (en) 2011-05-06
JP2010150259A (ja) 2010-07-08
SA109310011B1 (ar) 2013-04-30
AU2009245875A1 (en) 2010-07-08
JP5276579B2 (ja) 2013-08-28
EP2202225B1 (fr) 2012-10-24
AR074845A1 (es) 2011-02-16
PA8855501A1 (es) 2010-07-27
UA102518C2 (ru) 2013-07-25
SG162671A1 (en) 2010-07-29
HRP20121044T1 (hr) 2013-01-31
ME02037B (me) 2013-04-30

Similar Documents

Publication Publication Date Title
SI2202225T1 (sl) Nov postopek sinteze ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino
EP2371998A4 (en) SPIN METHOD
IL219796A0 (en) Method for producing 5,5-disubstituted 4,5-dihydroisoxazol-3-thiocarboxamidine salts
EP2116575A4 (en) PROCESS FOR PRODUCING POLYLACTIC ACID
EP2196534A4 (en) RECOMBINANT MICROORGANISM AND METHOD FOR PRODUCING POLY GAMMA GLUTAMINE ACID
EP2175029A4 (en) LACTIC PRODUCTION PROCESS
MA31149B1 (fr) Nouveau procede de preparation de benzocyclobutenes fonctionnalises, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutique acceptable
EP2436443A4 (en) PROCESS FOR PRODUCING CATALYST FOR PRODUCING METHACRYLIC ACID, AND PROCESS FOR PRODUCING METHACRYLIC ACID
ZA201105172B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
EP2302066A4 (en) METHOD FOR PRODUCING AMINOHYDROXYBENZOIC ACID
EP2377926A4 (en) CHONDROCYTE TYPE CELL, AND PROCESS FOR PRODUCING THE SAME
LT2236610T (lt) Patobulintas promotorius ir jo panaudojimas l-lizino gamybos būdui
ZA201201329B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
HK1150163A1 (en) Method for preparing trifluoromethanesulphinic acid
PL2487158T3 (pl) Nowy sposób syntezy iwabradyny i jej soli addycyjnych z kwasem farmaceutycznie dopuszczalnym
HK1169827A1 (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
IL210278A0 (en) Method for producing 3 - methyl - 2 - thiophenecarboxylic acid
EP2455342A4 (en) COBALT AND CERIUM COMPOUND, ALKALINE STORAGE BATTERY, AND PROCESS FOR PRODUCING COBALT AND CERIUM COMPOUND
EP2368705A4 (en) PROCESS FOR PREPARING A BAG AND BAG
SG10201400650QA (en) Method For Producing L-Amino Acid
SI2607353T1 (sl) Nov postopek sintetize ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino
SI2364972T1 (sl) Nov postopek za sintezo ivabradina in njegovih dodatnih soli
PL2268427T3 (pl) Sposób eksploatacji walcowni ziemnej o ulepszonej dynamice
EP2327789A4 (en) NEW COMPOUND SIGNAMYCIN, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
HK1193409A1 (zh) 合成 -溴- -二甲氧基苯基 丙腈的新方法以及在合成伊伐布雷定和其與藥學上可接受的酸的加成鹽中的應用